Novozymes B A/S

NZYM-B 
(NasdaqOMXC) 
 
dkk 317.90
Updated 23/02/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 0
High DKK 0
Low DKK 0
Open DKK0
ISIN DK0060336014
Prev close DKK319.00
# of shares 251.26M
Market cap 79,874M DKK
Intraday

Market closed
Novozymes B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  317.90 -1.3% Stock price decreasing -3.7% Stock price decreasing -7.2% Stock price decreasing 0.5% Stock price increasing 18.6% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
14,002
3,884
2,825
11,593
17,791
2014
12,459
3,384
2,526
11,280
18,426
2013
11,746
2,901
2,200
11,066
16,506
2012
11,234
2,745
2,015
9,568
15,113
2011
10,510
2,340
1,828
8,824
13,842
2010
9,724
2,117
1,614
7,836
12,593
2009
8,448
1,688
1,194
5,841
0
2008
8,146
1,504
1,062
4,465
0
2007
7,438
1,481
1,042
3,657
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Archer-Daniels-Midland Company 42.57 -1.3% Stock price decreasing -0.7% Stock price decreasing 8.8% Stock price increasing 2.0% Stock price increasing -5.9% Stock price decreasing 6.2% Stock price increasing
 
Internationa Flavors & Fragran.. 145.82 2.8% Stock price increasing -5.8% Stock price decreasing -4.3% Stock price decreasing 7.3% Stock price increasing 16.7% Stock price increasing -4.4% Stock price decreasing
 
Procter & Gamble Company (The) 81.05 -1.9% Stock price decreasing -8.3% Stock price decreasing -8.4% Stock price decreasing -12.4% Stock price decreasing -11.0% Stock price decreasing -11.8% Stock price decreasing
 
KAO Corp 56.18 -3.8% Stock price decreasing 0.3% Stock price increasing 6.7% Stock price increasing 10.9% Stock price increasing 86.4% Stock price increasing 0.9% Stock price increasing
 
Lonza Group AG NA SF 1 211.70 -1.2% Stock price decreasing -7.4% Stock price decreasing -4.5% Stock price decreasing 2.0% Stock price increasing 157.5% Stock price increasing -5.6% Stock price decreasing
 
Reckitt Benckiser Group PLC OR.. 5,918.10 -9.9% Stock price decreasing -13.3% Stock price decreasing -8.5% Stock price decreasing -19.8% Stock price decreasing -19.1% Stock price decreasing -14.5% Stock price decreasing
 
Basf SE NA O.N. 88.07 1.5% Stock price increasing -7.5% Stock price decreasing -7.4% Stock price decreasing 7.0% Stock price increasing 0.8% Stock price increasing -4.0% Stock price decreasing
 
Givaudan SA NA SF 10 1,923.00 3.4% Stock price increasing -0.4% Stock price decreasing 0.9% Stock price increasing 11.2% Stock price increasing 11.5% Stock price increasing 0.0% Stock price increasing
 
Monsanto Company 121.74 0.8% Stock price increasing -0.5% Stock price decreasing 3.1% Stock price increasing 4.2% Stock price increasing 7.8% Stock price increasing 4.2% Stock price increasing
 
DSM KON 84.24 -1.0% Stock price decreasing 0.8% Stock price increasing 7.9% Stock price increasing 30.2% Stock price increasing 37.2% Stock price increasing 5.7% Stock price increasing
 
Solvay 114.60 2.2% Stock price increasing -3.6% Stock price decreasing -3.9% Stock price decreasing -7.0% Stock price decreasing 2.4% Stock price increasing -1.1% Stock price decreasing
 
Unilever DR 43.49 -1.1% Stock price decreasing -6.3% Stock price decreasing -10.3% Stock price decreasing -12.9% Stock price decreasing -2.2% Stock price decreasing -7.4% Stock price decreasing
 
Givaudan N 2,158.00 0.0% Stock price decreasing -4.0% Stock price decreasing -3.3% Stock price decreasing 9.7% Stock price increasing 18.5% Stock price increasing -4.2% Stock price decreasing
 
Lonza N 240.40 -2.4% Stock price decreasing -10.1% Stock price decreasing -7.1% Stock price decreasing 1.1% Stock price increasing 33.6% Stock price increasing -8.7% Stock price decreasing
 
Cropenergies AG 6.26 0.0% Stock price unchanged -16.0% Stock price decreasing -28.5% Stock price decreasing -34.5% Stock price decreasing -19.3% Stock price decreasing -19.6% Stock price decreasing
 
Codexis Inc 9.15 -2.1% Stock price decreasing 6.4% Stock price increasing 46.4% Stock price increasing 72.6% Stock price increasing 123.2% Stock price increasing 9.6% Stock price increasing
 
Chr Hansen Holding A/S 509.00 -2.8% Stock price decreasing -4.9% Stock price decreasing -12.1% Stock price decreasing -3.4% Stock price decreasing 22.6% Stock price increasing -12.5% Stock price decreasing
Indices Open
 
OMX Copenhagen 20 CAP 1,149.43 0.8% Stock price increasing 0.8% Stock price increasing 3.5% Stock price increasing -1.5% Stock price decreasing 7.9% Stock price increasing 0.5% Stock price increasing

Company profile

Novozymes(NZYM) is split in two business divisions: Enzymes Business and BioBusiness. NZYM is the world’s leading player within industrial enzymes with 47% of the global market, which is estimated to be around DKK 19bn in total. Enzymes comprises the largest part of the revenue (2010: 94%, 2009: 92%) and is split into four sub segments of which one is technical enzymes, where sales of enzymes to the bioethanol industry take place (2010 Rev: 19%, mainly from North America). NZYM invests a large part of their R&D costs in development of bioethanol; massive production will however not take place before 2012/13. The largest competitors in this segment are Danisco and DSM. NZYM puts its focus on cost reductions, innovation and efficiency, seeing growth opportunities in the developing world. NZYM has no plans of major acquisitions after having acquired EMD/Merck Crop BioScience in 2011. With over 6,500 granted or pending patents, NZYM aims to achieve long-term organic sales growth of more than 10% p.a (hist.avg.: 8-9%) and increased dividend pay-out ratio to 35% of net profit (curr.: 30%).

Peers

Indices Last Change  
OMX C20 Cap 1,149.43 0.0% Stock price unchanged
13,25,24,5,25,35,70,99,72,85
Instruments Last Change  
Archer-Danie.. 42.57 0.0% Stock price unchanged
Internationa.. 145.82 0.0% Stock price unchanged
Procter & Ga.. 81.05 0.0% Stock price unchanged
KAO Corp 56.18 0.0% Stock price unchanged
Lonza Group .. 211.70 0.0% Stock price unchanged
0,0,0,0,0,0,0,0,0,0
Reckitt Benc.. 5,918.10 0.0% Stock price unchanged
Basf SE NA O.. 88.07 0.0% Stock price unchanged
Givaudan SA .. 1,923.00 0.0% Stock price unchanged
Monsanto Com.. 121.74 0.0% Stock price unchanged
DSM KON 84.24 0.0% Stock price unchanged
Solvay 114.60 0.0% Stock price unchanged
Unilever DR 43.49 0.0% Stock price unchanged
Givaudan N 2,158.00 0.0% Stock price unchanged
100,73,21,36,47,31,47,31,15,42
Lonza N 240.40 0.0% Stock price unchanged
100,64,37,62,59,46,27,14,5,35
Cropenergies.. 6.26 0.0% Stock price unchanged
Codexis Inc 9.15 0.0% Stock price unchanged
50,50,50,100,100,100,50,75,0,0
Chr Hansen H.. 509.00 0.0% Stock price unchanged
96,93,94,92,91,92,94,95,84,94

Targets for: Novozymes B A/S

Ritzau Finans
 
Analyst
Target
Date
Novozymes/Danske: Sænker kursmålet til 375 kr. fra 395 kr.
Danske Bank
375 ned
08/02/18
Novozymes/Deutsche: Kursmål løftes til 310 kr. fra 280 kr.
Deutsche Bank
310 op
04/12/17
Novozymes/Bernstein: Løfter kursmål til 350 kr. fra 330 kr. - NY
Bernstein
350 op
21/09/17
Novozymes/UBS: Indleder dækning med
UBS
240
19/06/17
Novozymes/Bernstein: Hæver kursmålet til 310 kr.
Bernstein
310 op
07/04/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 February 2018 01:42:29
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180222.1 - EUROWEB5 - 2018-02-25 02:42:29 - 2018-02-25 01:42:29 - 1000 - Website: OKAY